2025 H1 China Laparoscopic Surgical Robot Public Hospital Tender Report: da Vinci Dominates with 16 Units, Domestic Brands Gain Ground with 9 Units

Source: MedRobot

Reprint Requirements: You can directly repost, but please credit the source at the beginning of the article.

1. General Overview: 25 units awarded, Da Vinci dominates, domestically produced brands continue to advance

According to incomplete statistics, from January 1, 2025, to June 30, 2025, public hospitals in China won bids for a total of [number] laparoscopic surgical robots.25 Units`, with a total winning bid amount of approximately`RMB 386 million。

Among them,da Vinci System (Intuitive/da Vinci) wins 16 bids, accounting for nearly 70%, continuing to maintain a dominant position in this category; Chinese brands combined won bids for 9 units, including MicroPort, SurgRobot, and Conavi Medical; some projects with undisclosed amounts were not included in the total.

Overall, laparoscopic surgical robots maintained a steady pace of winning bids in the first half of 2025, making them the largest and most competitively mature category of surgical robots in terms of bidding volume.

2. Brand Distribution: Da Vinci Still Leads, Chinese Brands Accelerate Expansion

From the brand structure:

• Da Vinci(Intuitive/da Vinci): 16 units, widely distributed in provincial, ministry-affiliated, and top-tier municipal hospitals, maintaining category leadership;

• MicroEdge（Edge Medical）: A total of 6 units were awarded (including multiple models such as MP2000 and MP1000), and they have been implemented in various regions across East, Central, and North China;

• Other Brands: MicroPort, Surecron, and Conavi each won one bid, showcasing the diverse trends of domestically produced brands in category expansion.

Notably, some domestically produced systems have achieved breakthroughs in provincial core hospitals, indicating that their performance stability and clinical acceptance are gradually improving.

3. Regional Distribution and Hospital Levels: From First-Tier Cities to Lower Levels, Regional Agglomeration Accelerates

Laparoscopic surgical robots win bidding projects across China in the first half of the yearMore than 10 provinces, with the highest concentration in the East China (Shandong, Zhejiang, Fujian), Southwest China (Sichuan, Chongqing), and Central South China (Hubei, Hunan) regions.

Typical中标 hospitals include:

• Provincial or Directly Affiliated Large Hospitals: Sichuan Provincial People's Hospital, First Affiliated Hospital of Zhejiang University School of Medicine, Affiliated Hospital of Qingdao University, Jiangsu Cancer Hospital;

• Prefecture-level Key Tertiary Hospital: Tianmen First People's Hospital, Bengbu Third People's Hospital, Jincheng People's Hospital;

• University-affiliated Hospital System: Guilin Hospital of Xiangya Second Hospital, Central South University, Third Affiliated Hospital of Southern Medical University, Qingdao Hospital of Peking University People's Hospital, etc.

This distribution indicates that the procurement of endoscopic surgical robots is moving from top-tier centralized hospitals to more core hospitals in prefecture-level cities, and the types of hospitals are showing a diversified pattern of "comprehensive + specialized" structure.

4. Price Range Observation: The mainstream price is concentrated in the range of 15 to 20 million yuan.

According to the statistics of the available winning bid amounts:

• Da Vinci System普遍 inRMB 14.99 million - RMB 27 millionRange;

• Chinese BrandThe price range is relatively wider, and some products are...12 million–19 million yuan；

• Individual Items(Such as Cornerstone training-purpose equipment) with a bid amount below 10 million yuan, mainly used for clinical teaching or projects with simpler functional configurations.

Overall, Chinese brands have a certain flexible space in terms of pricing, but the prices of some equipment have approached the lower range of imported brands, indicating their progress in functional configuration and compatibility with surgical procedures.

5. Trend Observation: Stable Structure with Changes, Accelerated Localization of Production in China, Diversified Competition

The market for endoscopic surgical robots is still dominated by imported brands, but the trend is undergoing subtle changes:

• Shipment volume of domestic brands continues to grow, no longer limited to "pilot demonstrations," but with the capability to win regular bids;

• Product forms are becoming increasingly diverse.Such as dual-arm systems, training systems, 4K fluorescence, and other differentiated configurations gradually entering clinical procurement;

• Procurement at the city level further expands to lower-tier cities., more municipal-level hospitals have begun to deploy endoscopic robots, with the covered population and application scenarios expanding simultaneously.

In the second half of the year, as equipment renewal demand is released and project implementation accelerates, laparoscopic robots are expected to remain the most active细分 market in surgical robotics, with brand competition becoming even more intense.

6. Conclusion: Continuous Release of Winning Projects, Increasing Clinical Acceptance

From the data of the first half of the year, laparoscopic surgical robots not only continued to maintain their advantage in the number of installations, but alsoBrand Structure, Hospital Type and Regional DistributionShowed the characteristic of "steady progress" in multiple dimensions.

While Da Vinci solidifies its market foundation, domestically produced brands are progressively optimizing products, building service capabilities, and expanding surgical applications to further enhance their market penetration. MedRobot will continue to track bidding dynamics of relevant categories and will launch an English version of its newsletter in the future, assisting global industry observers in gaining a more comprehensive understanding of the Chinese market.